Research Papers

25 of 5402 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis.
Alferiev IS; Zhang K; Folchman-Wagner Z; Adamo RF; Guerrero DT; Fishbein I; Soberman D; Levy RJ; Chorny M.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PEG-Lipid-PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs.
Ismail J; Klepsch LC; Dahlke P; Tsarenko E; Vollrath A; Pretzel D; Jordan PM; Rezaei K; Czaplewska JA; Stumpf S; Beringer-Siemers B; Nischang I; Hoeppener S; Werz O; Schubert US.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establis…
Khan KA; Ahmad A; Marini C; Nicotra M; Di Cerbo A; Fazal-Ur-Rehman; Ullah N; Khan GM.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles.
Anindita J; Tanaka H; Yamakawa T; Sato Y; Matsumoto C; Ishizaki K; Oyama T; Suzuki S; Ueda K; Higashi K; Moribe K; Sasaki K; Ogura Y; Yonemochi E; Sakurai Y; Hatakeyama H; Akita H.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Controlling the Quality of Nanodrugs According to Their New Property-Radiothermal Emission.
Petrov GV; Galkina DA; Koldina AM; Grebennikova TV; Eliseeva OV; Chernoryzh YY; Lebedeva VV; Syroeshkin AV.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments.
Avgoustakis K; Angelopoulou A.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features.
Wilkins CA; Hamman H; Hamman JH; Steenekamp JH.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironmen…
Cecchi D; Jackson N; Beckham W; Chithrani DB.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Advances in Antitumor Effects Using Liposomal Citrinin in Induced Breast Cancer Model.
Moura MLV; de Menezes APM; de Oliveira Filho JWG; do Nascimento MLLB; Dos Reis AC; Ribeiro AB; da Silva FCC; Nunes AMV; Rolim HML; de Carvalho Melo Cavalcante AA; Sousa JMCE.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Tunable Glycosaminoglycan-Peptide Nanoparticle Platform for the Protection of Therapeutic Peptides.
Sodhi H; Panitch A.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A System for Discovering Novel Uricosurics Targeting Urate Transporter 1 Based on In Vitro and In Vivo Modeling.
Li X; Qi C; Shao M; Yang Y; Wang Y; Li J; Xiao Z; Ye F.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance.
Zhang L; Tian X; Sun L; Mi K; Wang R; Gong F; Huang L.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
An Overview of Biofilm-Associated Infections and the Role of Phytochemicals and Nanomaterials in Their Control and Prev…
Damyanova T; Dimitrova PD; Borisova D; Topouzova-Hristova T; Haladjova E; Paunova-Krasteva T.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives.
Peng S; Wang W; Zhang R; Wu C; Pan X; Huang Z.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The Fabrication of Polymer-Based Curcumin-Loaded Formulation as a Drug Delivery System: An Updated Review from 2017 to …
Azad AK; Lai J; Sulaiman WMAW; Almoustafa H; Alshehade SA; Kumarasamy V; Subramaniyan V.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Innovative Multilayer Electrospun Patches for the Slow Release of Natural Oily Extracts as Dressings to Boost Wound Hea…
Fiaschini N; Carnevali F; Van der Esch SA; Vitali R; Mancuso M; Sulli M; Diretto G; Negroni A; Rinaldi A.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Chitosan-Functionalized Poly(β-Amino Ester) Hybrid System for Gene Delivery in Vaginal Mucosal Epithelial Cells.
Gao X; Dong D; Zhang C; Deng Y; Ding J; Niu S; Tan S; Sun L.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Triphenylphosphonium Analogs of Short Peptide Related to Bactenecin 7 and Oncocin 112 as Antimicrobial Agents.
Tereshchenkov AG; Khairullina ZZ; Volynkina IA; Lukianov DA; Nazarov PA; Pavlova JA; Tashlitsky VN; Razumova EA; Ipatova DA; Timchenko YV; Senko DA; Efremenkova OV; Paleskava A; Konevega AL; Osterman IA; Rodin IA; Sergiev PV; Dontsova OA; Bogdanov AA; Sumbatyan NV.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nanocellulose, the Green Biopolymer Trending in Pharmaceuticals: A Patent Review.
Garcia KR; Beck RCR; Brandalise RN; Dos Santos V; Koester LS.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients…
Dong S; Shao G; Davies Forsman L; Wang S; Wang S; Cao J; Bao Z; Bruchfeld J; Alffenaar JC; Liu J; Hu Y; Wu M.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition …
Vora LK; Tekko IA; Zanutto FV; Sabri A; Choy RKM; Mistilis J; Kwarteng P; Jarrahian C; McCarthy HO; Donnelly RF.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Flavonoid-Labeled Biopolymer in the Structure of Lipid Membranes to Improve the Applicability of Antioxidant Nanovesicl…
Mathews PD; Gama GS; Megiati HM; Madrid RRM; Garcia BBM; Han SW; Itri R; Mertins O.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.
Mroué M; Bessaguet F; Nizou A; Richard L; Sturtz F; Magy L; Bourthoumieu S; Danigo A; Demiot C.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compar…
Gurtsieva D; Minskaia E; Zhuravleva S; Subcheva E; Sakhibgaraeva E; Brovin A; Tumaev A; Karabelsky A.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The Impact of Various Poly(vinylpyrrolidone) Polymers on the Crystallization Process of Metronidazole.
Orszulak L; Lamrani T; Tarnacka M; Hachuła B; Jurkiewicz K; Zioła P; Mrozek-Wilczkiewicz A; Kamińska E; Kamiński K.
Pharmaceutics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared